Alphatec Spine signs new exclusive supply agreement Alphatec Holdings, the parent company of Alphatec Spine, announced that the company has signed a new supply agreement that provides the Company with exclusive worldwide rights to market, sell and distribute an anchored, zero-profile anterior cervical interbody device. The device's 510K application is currently under review by the U.S. FDA for market clearance. Pursuant to the agreement, Alphatec Spine will pay an upfront fee over the next 12 months and has agreed to certain minimum purchase commitments. The market for cervical interbody devices is estimated to be $465M. The anchored interbody device market is the fastest growing segment of the cervical interbody market and is estimated to currently be approximately $47M.